| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |